Posted by undopaminergic on August 25, 2022, at 12:16:45
In reply to FDA approves Axsome (dextromethorphan + bupropion), posted by SLS on August 24, 2022, at 11:11:16
> ... The dextromethorphan component targets the N-methyl D-aspartate (NMDA) receptor and the sigma-1 receptor in the brain, while the bupropion component acts to increase levels of dextromethorphan in the blood."
>
> "The drug, Auvelity, ...This is the one I reported a few days ago. Thanks for the added information (above).
-undopaminergic
poster:undopaminergic
thread:1120470
URL: http://www.dr-bob.org/babble/20220530/msgs/1120484.html